Brief: ALX Oncology Reports Third Quarter 2022 Financial Results, Provides Clinical Development, Operational Highlights

ALX Oncology Holdings

08/11/2022 23:05

Nov 8 (Reuters) - ALX Oncology Holdings Inc  ALXO.O :
    * ALX ONCOLOGY REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
    * Q3 GAAP LOSS PER SHARE $0.87
    * Q3 EARNINGS PER SHARE VIEW $-0.77 -- REFINITIV IBES DATA
    * ALX ONCOLOGY-BELIEVES CASH, CASH EQUIVALENTS, INVESTMENTS,
ABILITY TO DRAW $50 MILLION OF TERM LOAN SUFFICIENT TO FUND
PLANNED OPERATIONS THROUGH MID-2025

Source text for Eikon:  ID:nGNXRN2ZF 
Further company coverage:  ALXO.O 
 ((Reuters.Briefs@thomsonreuters.com;))